The Long‐term Efficacy of Botulinum Toxin Injection to Treat Retrograde Cricopharyngeus Dysfunction
Open Access
Abstract
Objectives: To report the percentage of patients with symptom relief 6 or more months after botulinum toxin injection into the cricopharyngeus muscle for retrograde cricopharyngeus dysfunction (R‐CPD).Study Design: Retrospective case series of consecutively treated patients.Setting: Tertiary care laryngology clinic.Subjects and Methods: A review was performed of the first 200 patients who were diagnosed with R‐CPD and treated with botulinum toxin injection into the cricopharyngeus muscle by a single surgeon. The study group was limited to those for whom a minimum of 6 months has elapsed since the injection. Items assessed were efficacy, safety, complications, and duration of benefit.Results: Of 200 patients treated, (99.5%) gained the ability to burp and 95% experienced relief of the cardinal symptoms of R‐CPD: inability to belch, socially awkward gurgling noises, abdominal/chest pressure and bloating, and excessive flatulence. For those who experienced relief, 159 (79.9%) maintained a satisfactory ability to burp after 6 months. Of those who did not maintain the ability, 12 underwent a second injection, 1 patient underwent 3 subsequent injections, and 3 patients underwent partial myotomy. No patients experienced complications of botulinum toxin injection itself, and 4 patients had complications from esophagoscopy or anesthesia.Conclusion: In a case series of 200 patients with retrograde cricopharyngeus dysfunction, 99% experienced relief of the cardinal symptoms and 79.9% experienced lasting relief of their symptoms beyond pharmacologic duration of action after a single injection of botulinum toxin into the cricopharyngeus muscle. Relief can be reestablished in the remainder via additional injection or cricopharyngeus myotomy.Keywords
This publication has 9 references indexed in Scilit:
- A Rare Case Involving the Inability to BelchInternal Medicine, 2019
- Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and TreatmentOTO Open, 2019
- OnabotulinumtoxinA for adductor spasmodic dysphonia (ADSD): Functional results and the role of dosageToxicon, 2018
- Long-term Dose Stability of OnabotulinumtoxinA Injection for Adductor Spasmodic Dysphonia: A 19-Year Single Institution ExperienceFrontiers in Surgery, 2017
- Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphoniaThe Laryngoscope, 2016
- Mechanisms of reflexes induced by esophageal distensionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2001
- A case of inability to belchJournal of Gastroenterology and Hepatology, 2001
- Chest pain and inability to belchGastroenterology, 1989
- Dysfunction of the belch reflexGastroenterology, 1987